| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC321 | |||||||||||||||||||||||
| Submitter : | Ms. Diane Baker | Date & Time: | 12/21/2006 09:12:54 | |||||||||||||||||||||
| Organization : | Esthetician | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I have been on Obagi products for 2yrs and if something is wrong I'd like to know but it seems, once again the FDA is comparing apples to oranges because they are studying the response of oral doses vs. topical...the way this product is used by the general public. | ||||||||||||||||||||||||